S100A2 and neoplasm: Recent studies have also shown that TGF-β1 can regulate the expression of S100A4, and cancer cells invasion mediated by TGF-β1 could be inhibited by S100A2 silence, indicating that S100A4 might be the molecular target of TGF-β1 in tumor metastasis [20].